SAE report triggers calls for FDA reform

In the wake of yesterday's news about adverse events, the FDA is getting a splash of cold water to the face. The Archives of Internal Medicine report showed a doubling of serious side effects, including death, from 1998 to 2005--and now, there's an outcry for reform.

But what to do? Congress is asking for money so the FDA can hire more scientists and drug-safety experts. Politicians also are calling on the agency to act on the adverse event data already collected. Meanwhile, the agency suggests that side effects may not have increased, just reporting of side effects. And the debate rages on.

- read the article from the Chicago Tribune

Related Articles:
Adverse drug events, deaths soar. Report
Poll finds problems at the FDA. Report
FDA offers safety reforms to skeptical lawmakers. Report
IOM slams FDA, calls for major reforms. Report
Pharmacovigilance grows in importance. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.